ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag vaccine politics innovation policy

Opinion: The Politics of Science and Racism
Sadye Paez and Erich D. Jarvis | Aug 18, 2020 | 7 min read
Race has been used to segment humanity and, by extension, establish and enforce a hierarchy in science. Individual and institutional commitments to racial justice in the sciences must involve political activity.
A stylized graphic of a hand reaching out with a key to unlock a bird cage, inside which sits a lightbulb
Biden Administration Backs Vaccine Intellectual Property Waiver
Amanda Heidt | May 10, 2021 | 4 min read
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Opinion: Scientists Must Battle the Disinformation Pandemic
Genna Reed | Oct 1, 2020 | 5 min read
Fighting the spread of an infectious disease goes hand in hand with stemming the dissemination of lies, bad science, and misdirection.
Biden administration, Trump administration, science policy, politics, research funding, public health, climate change, NSF, NIH, CDC
Science Advocates’ Wishlist for the Biden Administration
Amanda Heidt | Jan 7, 2021 | 6 min read
From immigration reform to climate change amelioration, researchers and science policy advocates share their hopes for 2021 and beyond.
European Research Council President Resigns
Amy Schleunes | Apr 8, 2020 | 3 min read
Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Trumping Science: Part II
Bob Grant | Dec 6, 2016 | 5 min read
As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.
An AIDS Vaccine by 2007? Not Likely, Say Participants
Myrna Watanabe | Jun 7, 1998 | 10 min read
May 18 marked the one-year anniversary of President Bill Clinton's pledge--some say more politically motivated than realistic--that there will be an AIDS vaccine by the year 2007. READY FOR PHASE III: Donald Francis of VaxGen is ready for Phase III trials of its AIDS vaccine to begin. The field of AIDS vaccine research has been and remains acrimonious. The basic researchers who insist on proof of immune response prior to large clinical trials disagree with the vaccine researchers whose experi
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Run a Search

ADVERTISEMENT